Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Histocell SL
Neuroplast Develops Safer Stem Cell Therapy For Spinal Injuries
Emerging Company Profile: The Dutch biotech is working on a more streamlined autologous stem cell therapy for traumatic spinal cord injury, an indication currently dominated by allogeneic treatments which present safety issues.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.